6609.HK实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (30 Apr 2024 @ 15:52):

Shanghai HeartCare Medical Technology Corporation Limited engages in the research, development, manufacture, and sale of neuro-interventional medical devices worldwide...

Stats
今日成交量	500.00
平均成交量	65 259.00
市值	669.00M
EPS	HKD0 ( 2024-03-28 )
下一个收益日期	( HKD0 ) 2024-05-20
Last Dividend	HKD0 ( N/A )
Next Dividend	HKD0 ( N/A )
P/E	-6.58
ATR14	HKD0.158 (0.88%)

音量相关性

長: -0.17 (neutral)

短: -0.61 (weak negative)

Signal:(37.393) Neutral

Shanghai HeartCare 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Shanghai HeartCare 相关性 - 货币/商品

0.76
( moderate )

0.82
( strong )

0.55
( weak )

0.69
( moderate )

-0.82
( strong negative )

-0.28
( neutral )

Shanghai HeartCare 财务报表

Annual	2023
营收:	HKD232.34M
毛利润:	HKD163.76M (70.48 %)
EPS:	HKD-2.47

FY	2023
营收:	HKD232.34M
毛利润:	HKD163.76M (70.48 %)
EPS:	HKD-2.47

FY	2022
营收:	HKD183.03M
毛利润:	HKD124.33M (67.93 %)
EPS:	HKD-5.24

FY	2021
营收:	HKD90.09M
毛利润:	HKD54.95M (61.00 %)
EPS:	HKD-6.18

Financial Reports:

No articles found.

Shanghai HeartCare

Shanghai HeartCare Medical Technology Corporation Limited engages in the research, development, manufacture, and sale of neuro-interventional medical devices worldwide. The company offers ischemic stroke thrombectomy, intracranial stenosis treatment, ischemic stroke prevention, hemorrhagic stroke treatment, and vascular access devices. Its products are used for the treatment and prevention of ischemic stroke, including acute ischemic stroke and intracranial stenosis, as well as for the treatment of hemorrhagic stroke. The company was formerly known as Shanghai Care Medical Technology Corporation Limited. Shanghai HeartCare Medical Technology Corporation Limited was incorporated in 2016 and is headquartered in Shanghai, the People's Republic of China.